Bruce J. Roth, MD

Bruce J. Roth, MD

Professor

Address:
Division of Oncology
Mail Stop 8056-0029-11
Washington University
660 South Euclid Avenue
St. Louis, MO 63110

Admin:
Chad Benson
bchad@wustl.edu

Research Interests
  • Prostate cancer
  • Urothelial carcinomas
  • Testicular cancer
  • Cancers of the kidney
Research

Dr. Roth’s research interests include the clinical development of novel therapeutics and novel combinations in advanced stages of prostate cancer, urothelial carcinomas, testicular cancer and cancers of the kidney, as well as new therapies in earlier stages of both prostate cancer and bladder cancer. Clinical trials in these areas range from multi-institutional, multinational or cooperative group trials comparing newer therapies to standards of care or to first-in-human trials of promising agents when no standard of care exists.

Profiles (publications)
WU Physician Bio

Biosketch

Education

  • 1980: MD, Saint Louis University, St. Louis, MO
  • 1976: BS in Pre-Professional Studies, University of Notre Dame, Notre Dame, IN

Post-Graduate Training

  • 1986-1983: Fellowship in Hematology/Oncology, Indiana University Medical Center, Indianapolis, IN
  • 1983-1981: Residency in Internal Medicine, Indiana University Medical Center, Indianapolis, IN
  • 1981-1980: Internship in Internal Medicine, Indiana University Medical Center, Indianapolis, IN

Academic Positions

  • present-2010: Professor of Medicine, Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO
  • 2010-1999: Professor of Medicine and Urologic Surgery, Vanderbilt-Ingram Cancer Center, Nashville, TN
  • 1999-1997: Professor of Medicine, Division of Hematology/Oncology, Indiana University Medical Center, Indianapolis, IN
  • 1997-1992: Associate Professor of Medicine, Division of Hematology/Oncology, Indiana University Medical Center, Indianapolis, IN
  • 1992-1986: Assistant Professor of Medicine, Division of Hematology/Oncology, Indiana University Medical Center, Indianapolis, IN

Board Certification

  • 1985: American Board of Internal Medicine, Medical Oncology
  • 1983: American Board of Internal Medicine, Internal Medicine

Honors & Awards

  • 2015, 2012, 2011: Highest Patient Satisfaction Award, Washington University in St. Louis
  • 2010: ASCO Statesman Award
  • 2009, 2007: 5-Star Patient Satisfaction Award, Vanderbilt University Medical Center
  • 1999: Paul V. Hamilton, MD and Virginia E. Howd Endowed Professor of Urologic Oncology
  • 1992-1989: American Cancer Society Clinical Oncology Career Development Award
  • 1989: American College of Physicians Fellow
  • 1986-1983: American Cancer Society Clinical Oncology Fellow

Editorial Responsibilities

  • current: Section Editor, Genitourinary Malignancies, CancerProgress.Net (ASCO)
  • 2012: Executive Editor, Cancer Clinical Advances
  • 2005: Guest Editor, Annual Meeting Summaries, Journal of Clinical Oncology
  • 2001: Guest Editor, Chemotherapy in Urologic Malignancies, Seminars in Urologic Oncology
  • 1992: Guest Editor, Testicular Cancer, Seminars in Oncology

Professional Organizations

  • American Society of Clinical Oncology
  • Alliance for Cancer Clinical Trials

Institutional Service

  • present-2015: Medical Director, Oncology Services, Siteman Cancer Center – South
  • 2019-2011: Medical Director, Oncology Services, Siteman Cancer Center – West

Extramural Activities

  • present-2020: Member, Independent Data Monitoring Committee for Seattle Genetics Trial EV-302
  • present-2014: Member, Medical Advisory Board, Testicular Cancer Foundation
  • present-2011: Member, American Urological Association Guidelines Panel for Castrate Resistant Prostate Cancer
  • 2018-2014: Member, Oncology Drug Advisory Committee of the Food and Drug Administration
    • Chairman, 2018-2016
  • 2012: Member, Testicular Cancer Program Committee, Society of Urologic Oncology
  • 2010-2008: Member, National Comprehensive Cancer Center Prostate Cancer Guidelines Panel
  • 2004-1995: Chairman, Prostate Cancer Committee, Eastern Cooperative Oncology Group
  • 2003-1999: Member, Genitourinary Concept Evaluation Panel, Chemotherapy Evaluation Program, National Cancer Institute
  • 2002-2001: Member, Clinical Trials Committee, Association of American Cancer Institutes
  • 2001: Member, Genitourinary Program Committee, Annual Meeting of the American Society of Clinical Oncology
  • 2000: Chairman, Genitourinary Program Committee, Annual Meeting of the American Society of Clinical Oncology
  • 2000: Chairman, Educational Session: “Integration of Surgery and Chemotherapy for Invasive Bladder Cancer”, Annual Meeting of the American Society of Clinical Oncology
  • 1999: Member, National Cancer Institute Consensus Panel on the Use of PSA as a Therapeutic Endpoint
  • 1999 -1986: Member, Hoosier Oncology Group
  • 1998: Chairman, Educational Session on Bladder Cancer at the Annual Meeting of the American Society of Clinical Oncology
  • 1993-1989: Member, Program Committee of the Annual Meetings of the Midwest Society for Pediatric Research/Central Society of Clinical Investigation/Midwest Section of the American Federation for Clinical Research
  • 1993-1990: Member, National Council of the American Federation for Clinical Research
  • 1993-1990: Secretary/Treasurer, Midwest Section of the American Federation for Clinical Research
  • 1992: Member, National Cancer Institute Special Emphasis Panel, New Therapeutic Approaches to The Treatment of Prostate Cancer, Bethesda, Maryland
  • 1990: Councilor, Midwest Section of the American Federation for Clinical Research
  • 1990-1988: Representative, The American Federation for Clinical Research, Indiana University School of Medicine
  • 1989: Co-Chairman, Consensus Group on Stage I Non-Seminomatous Germ Cell Tumors and the Consensus Group on Long-Term Effects of Therapy at the Consensus Development Conference on Testicular Cancer and Prostatic Carcinoma, University of Hull, North Humberside, England

American Society of Clinical Oncology Leadership

  • present-2010: Specialty Editor (Testicular Cancer) for CancerProgress.net
  • 2016-2015: Member, Bylaws Committee
  • 2015-2014: Chair, Bylaws Committee
  • 2014-2013: Chair-Elect, Bylaws Committee
  • 2014-2011: Member, Timely Oncology Perspectives Team
  • 2014-2011: Member, Genitourinary Cancer Symposium News Planning Team
  • 2013-2012: Chair, Cancer Communications Committee
  • 2013-2010: Member, Planning Committee, Oncology Literature Reviews
  • 2012-2011: Chair-Elect, Cancer Communications Committee
  • 2012-2011: Member, ASCO PSA Testing for Prostate Cancer Screening Expert Panel
  • 2010-2012 Chairman, Expert Panel, “On The Line” Prostate Cancer Awareness Campaign, ASCO/ESPN
  • 2009-2007: Board of Directors Liason to Communications Committee
  • 2009-2006: Treasurer
  • 2009-2006: Member, Board of Directors
  • 2009-2006: Member, Executive Committee of Board of Directors
  • 2009-2006: Chairman, Finance Committee
  • 2009-2006: Member, Audit Committee (ex-officio)
  • 2008-2007: Chairman, Program Committee, 2008 Genitourinary Oncology Symposium
  • 2007-2006: Chair-Elect, Program Committee, 2007 Prostate Cancer Symposium
  • 2006: Chairman, “Best of ASCO” Program Committee
  • 2005-2004: Chairman, Scientific Programs Committee
  • 2005-2003: Member, Education Committee
  • 2004-2003: Chair-Elect, Scientific Programs Committee